FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:891-892 March 30, 1995 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Connor, E. M. PubMed Citation

To the Editor: Despite the strong evidence reported by Connor et al. (Nov. 3. issue)¹ that zidovudine therapy administered to pregnant woman with human immunodeficiency virus (HIV) infection can significantly reduce the risk of maternal–infant transmission of the virus, in an accompanying editorial, Bayer maintains that compulsory testing and treatment of pregnant women for HIV disease violate the principle of consent and so are unjustified.² We believe this claim is too strong. Compulsory testing, although not treatment, may be justified.

Bayer errs in conflating compulsory unblinded testing of pregnant women with compulsory treatment of competent adults. The arguments he offers, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.